EMA Acts To Freeze Drugs Linked to GVK Bio, Guards Against Shortages
This article was originally published in The Pink Sheet Daily
Executive Summary
EMA has recommended suspension of some 700 drug formations linked with Indian clinical trials company GVK Biosciences, but assures national agencies that this won’t result in shortages or safety issues.